PATENT CLAIM ANALYSIS

Application Number: 15965860
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "456000"]

Abstract:
The present invention discloses a method for preventing or treating heart failure, relating to a novel use of nobiletin, the nobiletin reverses cardiac remodeling after heart failure and ischemia, the reversion of cardiac remodeling caused by ischemic heart failure includes reversing the increase of systolic ventricular internal dimension, reversing the decrease of ventricular ejection fraction and ventricular fractional shortening, reducing infarct size, and promoting cardiomyocyte survival rate. The present invention reveals the use of nobiletin in preventing or treating heart failure.

Claim (Index 8):
A method for preventing or treating heart failure in a patient comprising administrating the pharmaceutical composition according to  claim 6  to the patient.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 91.0
- Lexical Diversity: 1.71154
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15028606', '13582724', '14255643', '14903624', '11287094']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7239526569345643
- 35 USC 102 Novelty (BERT): 0.5117285777737739
- Combined Prediction Score: 0.7027302490184852
- Mean Citation Score: 269.82446400000003
- Max Citation Score: 276.24942000000004
- Similarity Product: 208.0890916369844

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test